what are the pros and cons of tirzepatide Split Dosing GLP1: My Experiment I Didn’t Expect THIS 😳 Semaglutide Tirzepatide (Zepbound, Mounjaro): Weight Loss,

Genetic factors, baseline metabolism, and adherence all influence the dose-response relationship

Symptom Tracking Keep a journal of side effects to discuss with your doctor during follow-ups

We dont know how the medicines interact with the human body

For every 1,000 people who take GLP-1 drugs, about 2 may get gallstones, and 4 may get acid reflux

[DOI] [PMC free article] [PubMed] [Google Scholar] 28.H

Clinical trials vs real-world results What the clinical trials show The landmark SURMOUNT-5 trial published in 2025 compared these medications directly at standard maximum doses: 1 Mounjaro (tirzepatide 15 mg) produced 20.2% average weight loss Wegovy (semaglutide 2.4 mg) produced 13.7% average weight loss The 6.5 percentage point difference was statistically significant This trial used the maximum approved doses at the time (Mounjaro 15 mg, Wegovy 2.4 mg) and lasted 72 weeks